Clinical Trials Browser

Terminated × Drug Therapy × Classical hematology × Clear all

NCT00740181 2022-01-14

Decitabine, Cytarabine, GCSF for Refractory AML/MDS

Phase 2 Terminated

9 enrolled 7 charts

Classical hematologyOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia